Vanda Pharmaceuticals (NASDAQ:VNDA) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a research note released on Wednesday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a “buy” rating and set a $18.00 target price on shares of Vanda Pharmaceuticals in a report on Tuesday. Check Out […]
More Stories
How ICE Was Targeted in Minneapolis for Weeks Before Fatal Shooting
By Jacki Thrapp MINNEAPOLIS—Activists in Minneapolis are continuing to organize efforts to impede immigration enforcement as the Trump administration surges...
Trump Says US Control of Greenland Would Make NATO Stronger
By Tom Ozimek President Donald Trump said on Jan. 14 that NATO would be a stronger and more credible deterrent...
Constraining Mega-Landlords Would Help Some Buyers, Won’t Solve Housing Woes: Industry Insiders
By Petr Svab President Donald Trump’s proposed ban on large corporate landlords buying more single-family homes could help families looking...
DHS Calls on Minnesota to Honor ICE Arrest Detainers of More Than 1,360 Criminal Illegal Aliens
By Naveen Athrappully The U.S. Department of Homeland Security (DHS) called on Governor Tim Walz and Minneapolis Mayor Jacob Frey...
Greenlandic, Danish Ministers to Meet With Vance, Rubio in Washington: Rasmussen
By Victor Friedman Danish Foreign Minister Lars Lokke Rasmussen said that he and his Greenlandic counterpart, Vivian Motzfeldt, will meet...
Minnesota Stealing: Reason to Rethink Government Welfare
By Larry Elder As for the estimated $8 billion in government (taxpayer) money stolen by crooks in Minnesota, people demand...